Ovintiv (NYSE:OVV – Get Rating) had its price objective increased by equities researchers at Morgan Stanley from $49.00 to $68.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 27.70% from the stock’s current […]